Image

Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients

Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients

Recruiting
18-45 years
Female
Phase N/A

Powered by AI

Overview

In view of the known link between pre-eclampsia, overweight/obesity and chronic kidney disease, the aim is to offer for obese and overweight patients to reduce their BMI without reducing lean body mass.

The POPADIPE project will make it possible to limit overweight or obesity by means of nutritional management chosen by the patient (hypocaloric or a dissociated diet). The latter has been the subject of little scientific investigation, particularly in relation to the management of post-pre-eclampsia.

Eligibility

Inclusion Criteria:

  • Person affiliated to social security
  • Free, informed and written consent signed by the participant and the investigator (no later than the day of day of inclusion and before any examination required by the research)
  • Patient over 18 years of age at the time of inclusion and < 45 years of age
  • Having had an pre-eclampsia in the last 5 years according to the definitions of the ISSHP 2018
  • Patient with a BMI between 25 kg/m² and 40 kg/m² who accepts dietetic follow up
  • Patient with a medical prescription for dietetic follow-up aimed at losing weight loss
  • Patient with a balanced diet

Exclusion Criteria:

  • Patients with a mental disability or language barrier that prevents them from understanding or consenting to the study
  • Patients deprived of their liberty by judicial or administrative decision
  • Patients under psychiatric care
  • Patients subject to a legal protection measure
  • Patients with cognitive disorders or defined eating disorders
  • Patients who are pregnant or breast-feeding
  • Patients undergoing steroid treatment and/or immunosuppression
  • Have been on a low-calorie or dissociated diet for at least 6 months
  • Patients with CKD stage ≥ 3A

Study details
    Pre-Eclampsia
    Obesity

NCT06067906

Centre Hospitalier le Mans

25 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.